UF researchers identify blood biomarker that could aid in Parkinson’s diagnosis
Discovery of protein changes in blood immune cells could pave the way for a simple screening test for Parkinson’s diagnosis.
Posted in
Parkinsons
Researchers report COVID-19 elevates risk of Parkinson’s in mice
Dr. Michael Okun weighs in on mouse-model study reporting that COVID-19 infection increased risk of Parkinson’s in mice.
Commentary: Understanding why DBS side effects happen and how we can minimize difficulties
Dr. Joshua Wong provides commentary on a research study that found brain signatures that may predict cognitive difficulty from STN DBS for Parkinson's disease.
Tracking the progression of Parkinson’s disease, MSA and PSP with advanced MRI imaging
UF Neuroscientists compare advanced MRI imaging to follow the progression of PD, MSA and PSP
Spaced physical therapy may support maintaining physical function in Parkinson’s disease
UF study provides evidence that spacing physical therapy sessions over time for persons with Parkinson’s disease may lead to a more stable longer-term outcome.
UF joins global study into Parkinson’s onset and progression
UF is now a site for worldwide study seeking new insights into Parkinson’s disease.
New hope for Parkinson’s
Dr. Michael Okun featured in AARP article about increased research funding for Parkinson’s.
AAN publishes new guidelines for early Parkinson’s disease treatment
Dr. Melissa Armstrong co-authored new guidance published in the journal Neurology.
UF joins global Parkinson’s research network
Aligning Sciences Across Parkinson’s (ASAP) accelerates research efforts into underlying causes of disease.
UF neurologists featured in Clinical Neurology Update
Drs. Michael Okun and Michael Jaffee contributed to a recent edition of NEJM Group publication.
